485 related articles for article (PubMed ID: 19149599)
1. Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.
Imai S
Curr Pharm Des; 2009; 15(1):20-8. PubMed ID: 19149599
[TBL] [Abstract][Full Text] [Related]
2. Nampt: linking NAD biology, metabolism and cancer.
Garten A; Petzold S; Körner A; Imai S; Kiess W
Trends Endocrinol Metab; 2009 Apr; 20(3):130-8. PubMed ID: 19109034
[TBL] [Abstract][Full Text] [Related]
3. Nampt and its potential role in inflammation and type 2 diabetes.
Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W
Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571
[TBL] [Abstract][Full Text] [Related]
4. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme.
Revollo JR; Körner A; Mills KF; Satoh A; Wang T; Garten A; Dasgupta B; Sasaki Y; Wolberger C; Townsend RR; Milbrandt J; Kiess W; Imai S
Cell Metab; 2007 Nov; 6(5):363-75. PubMed ID: 17983582
[TBL] [Abstract][Full Text] [Related]
5. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.
Revollo JR; Grimm AA; Imai S
Curr Opin Gastroenterol; 2007 Mar; 23(2):164-70. PubMed ID: 17268245
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of Nampt gene expression regulation].
Huang R; Wang ZR; Sun Y; Zhang G; Lu YP
Yi Chuan; 2012 Dec; 34(12):1561-9. PubMed ID: 23262103
[TBL] [Abstract][Full Text] [Related]
7. NAMPT: A critical driver and therapeutic target for cancer.
Gasparrini M; Audrito V
Int J Biochem Cell Biol; 2022 Apr; 145():106189. PubMed ID: 35219878
[TBL] [Abstract][Full Text] [Related]
8. Physiological and pathophysiological roles of NAMPT and NAD metabolism.
Garten A; Schuster S; Penke M; Gorski T; de Giorgis T; Kiess W
Nat Rev Endocrinol; 2015 Sep; 11(9):535-46. PubMed ID: 26215259
[TBL] [Abstract][Full Text] [Related]
9. SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice.
Yoon MJ; Yoshida M; Johnson S; Takikawa A; Usui I; Tobe K; Nakagawa T; Yoshino J; Imai S
Cell Metab; 2015 May; 21(5):706-17. PubMed ID: 25921090
[TBL] [Abstract][Full Text] [Related]
10. Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders.
Dakroub A; A Nasser S; Younis N; Bhagani H; Al-Dhaheri Y; Pintus G; Eid AA; El-Yazbi AF; Eid AH
Cells; 2020 Nov; 9(11):. PubMed ID: 33182523
[TBL] [Abstract][Full Text] [Related]
11. Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.
Wang T; Zhang X; Bheda P; Revollo JR; Imai S; Wolberger C
Nat Struct Mol Biol; 2006 Jul; 13(7):661-2. PubMed ID: 16783373
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.
Chen H; Wang S; Zhang H; Nice EC; Huang C
Expert Rev Anticancer Ther; 2016 Aug; 16(8):827-38. PubMed ID: 27186719
[TBL] [Abstract][Full Text] [Related]
13. Autocrine effects of visfatin on hepatocyte sensitivity to insulin action.
Skop V; Kontrová K; Zídek V; Pravenec M; Kazdová L; Mikulík K; Sajdok J; Zídková J
Physiol Res; 2010; 59(4):615-618. PubMed ID: 19929131
[TBL] [Abstract][Full Text] [Related]
14. Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin.
Carbone F; Liberale L; Bonaventura A; Vecchiè A; Casula M; Cea M; Monacelli F; Caffa I; Bruzzone S; Montecucco F; Nencioni A
Compr Physiol; 2017 Mar; 7(2):603-621. PubMed ID: 28333382
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma.
Hara N; Yamada K; Shibata T; Osago H; Tsuchiya M
PLoS One; 2011; 6(8):e22781. PubMed ID: 21826208
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.
Jacques C; Holzenberger M; Mladenovic Z; Salvat C; Pecchi E; Berenbaum F; Gosset M
J Biol Chem; 2012 Apr; 287(18):15100-8. PubMed ID: 22399297
[TBL] [Abstract][Full Text] [Related]
17. Design of FK866-Based Degraders for Blocking the Nonenzymatic Functions of Nicotinamide Phosphoribosyltransferase.
Lu T; Chen F; Yao J; Bu Z; Kyani A; Liang B; Chen S; Zheng Y; Liang H; Neamati N; Liu Y
J Med Chem; 2024 May; 67(10):8099-8121. PubMed ID: 38722799
[TBL] [Abstract][Full Text] [Related]
18. Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α-mediated Apoptosis in Human Lung Endothelial Cells.
Oita RC; Camp SM; Ma W; Ceco E; Harbeck M; Singleton P; Messana J; Sun X; Wang T; Garcia JGN
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):36-44. PubMed ID: 29337590
[TBL] [Abstract][Full Text] [Related]
19. Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders.
Moschen AR; Gerner RR; Tilg H
Curr Pharm Des; 2010 Jun; 16(17):1913-20. PubMed ID: 20370672
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD.
Busso N; Karababa M; Nobile M; Rolaz A; Van Gool F; Galli M; Leo O; So A; De Smedt T
PLoS One; 2008 May; 3(5):e2267. PubMed ID: 18493620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
